Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-04-08
2008-04-08
Maier, Leigh C. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
10492947
ABSTRACT:
An agent for treating inflammatory bowel diseases and an agent for preventing or improving symptoms accompanied by inflammatory bowel diseases, which each comprises hyaluronic acid or a pharmaceutically acceptable salt thereof as an active ingredient.
REFERENCES:
patent: 4141973 (1979-02-01), Balazs
patent: 4725585 (1988-02-01), Wenge et al.
patent: 5234914 (1993-08-01), Gallina
patent: 5811410 (1998-09-01), Falk et al.
patent: WO 00/29030 (2000-05-01), None
patent: WO 01/58457 (2001-08-01), None
Verspaget, H. et al “Diminished neutrophil function in Crohn's disease and ulcerative colitis . . . ” Gut (1988) vol. 29, pp. 223-228.
Zhang, K. et al “Influence of polysaccharides on neutrophil function . . . ” J. Cell. Biochem. (1994) vol. 56, pp. 225-235.
International Search Report dated Nov. 26, 2002.
XP-002400776,(1978) “The glycosaminoglycans of the human colon in inflammatory and neoplastic conditions”, vol. 102, No. 3, abstract only.
XP-002400778 (1999) “Kallikrein-kinin system inhibitor—contains acid muco-polysaccharide”, Derwent Publications Ltd.
Supplementary Partial European Search Report dated Oct. 10, 2006.
Maier Leigh C.
Seikagaku Kogyo Kabushiki Kaisha
LandOfFree
Agent for treating inflammatory bowel diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for treating inflammatory bowel diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treating inflammatory bowel diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3913195